FDA PMA FDA Class 3 Approved 🇺🇸 United States

Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer

PMA: P000021 · Supplement: S017 · Decision Sep 2, 2010
Classifications
1
FEI Numbers
15
Registration Numbers
15

Basic Information

Device Name
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
Trade Name
DIMENSIONS TPSA FLE REAGENT CARTRIDGE
PMA Number
P000021
Supplement Number
S017
Device Class
FDA Class 3
Product Code
MTF
Generic Name
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
Medical Specialty
Unknown
Advisory Committee
Immunology
Decision
Approved
Decision Code
APPR
Decision Date
September 2, 2010
Date Received
July 6, 2010
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE ADDITION OF A CLOT CHECK DEVICE TO THE DIMENSION EXL WITH LM SYSTEM WHEN USED WITH THE DIMENSION TPSA FLEX REAGENT CARTRIDGE.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MTF Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer